The APC gene in colorectal cancer
Introduction
Colon cancer is one of the most common malignancies among populations in the US and Western Europe, and one of the leading causes of worldwide morbidity and mortality due to cancer. In the US, approximately 140 000 new cases and 50 000 deaths are registered each year [1]. In Europe, each year about 213 000 new cases and 110 000 deaths are reported, respectively [2] (see also: http://www-dep.iarc.fr). The lifetime colorectal cancer risk in the general population is 5%, but this figure rises dramatically with age: by the age of 70 years, approximately half the Western population will have developed an adenoma. In general, the incidence of colorectal cancer is high in developed countries, with incidence rates varying up to 20-fold between high- and low-risk geographical areas throughout the world [2]. These variations in colorectal cancer incidence are likely to result from environmental and mainly dietary modifying factors.
Colorectal carcinomas arise through a series of well-characterised histopathological changes as the result of specific genetic ‘hits’ at a few oncogenes and tumour suppressor genes. At least four sequential genetic changes need to occur to ensure colorectal cancer evolution (Fig. 1). One oncogene (KRAS) and three tumour suppressor genes (adenomatous polyposis coli (APC), SMAD4 and TP53) are the main targets of these genetic changes. In particular, loss of APC gene function seems to trigger the cascade of events that eventually leads to malignant transformation in the large bowel. Here, I will focus on the function of the APC gene in homeostasis and cancer, as this knowledge is expected to provide the basis for the development of future tailor-made preventive and therapeutic interventions for colorectal cancer.
Section snippets
The APC gene in homeostasis and cancer
The APC gene was initially identified by positional cloning of the FAP (familial adenomatous polyposis) locus 3, 4. Subsequently, the majority of sporadic colorectal tumours were found to harbour mutations in both APC alleles 5, 6. Initially, the sequence of the large (312 kDa) APC protein did not allow specific predictions about its intracellular function. The first functional clues were provided by the identification of β-catenin as a binding partner of APC 7, 8. β-catenin was originally
A genetic model for APC-driven colorectal tumorigenesis
A general picture is emerging from the analysis of the essential roles of the Wnt signal transduction pathway in providing selective advantage to the nascent tumour cell, and in exerting genetic instability to ensure both tumour progression and malignant transformation: the APC gene, because it encompasses both functions, plays a central initiating and promoting role in colorectal cancer. Its inactivation and the resulting constitutive activation of the Wnt pathway provides a strong selective
References (60)
- et al.
Identification and characterization of the familial adenomatous polyposis coli gene
Cell
(1991) - et al.
Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta
Curr. Biol.
(1998) - et al.
XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos
Cell
(1996) - et al.
Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer
Curr. Opin. Cell. Biol.
(1998) - et al.
Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel
Gastroenterology
(1988) - et al.
Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa
Hum. Pathol.
(1989) - et al.
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer
Am. J. Pathol.
(1999) - et al.
Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway
Am. J. Pathol.
(1999) - et al.
Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas
Am. J. Pathol.
(2000) - et al.
Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium
Am. J. Pathol.
(1999)
Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front
Pathol. Res. Pract.
E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice
Gastroenterology
Cancer statistics, 2000
Ca Cancer J. Clin.
Estimates of the worldwide mortality from 25 cancers in 1990
Int. J. Cancer
Identification of FAP locus genes from chromosome 5q21
Science
APC mutations occur early during colorectal tumorigenesis
Nature
Mutations of the APC (adenomatous polyposis coli) gene
Hum. Mutat.
Association of the APC tumor suppressor protein with catenins
Science
Association of the APC gene product with beta-catenin
Science
Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta
Science
Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization
J. Cell. Biol.
Axin prevents Wnt-3a-induced accumulation of beta-catenin
Oncogene
A new member of the frizzled family from Drosophila functions as a Wingless receptor
Nature
Functional interaction of beta-catenin with the transcription factor LEF-1
Nature
The APC gene product associates with microtubules in vivo and promotes their assembly in vitro
Cancer Res.
Wild-type but not mutant APC associates with the microtubule cytoskeleton
Cancer Res.
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC−/− colon carcinoma (see comments)
Science
Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC (see comments)
Science
Apc1638Ta mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development
Genes Dev.
Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer
Cancer Res.
Cited by (324)
Pathological role of long non-coding (lnc) RNA in the regulation of Wnt/β-catenin signaling pathway during epithelial-mesenchymal transition (EMT)
2023, Pathology Research and PracticeColon cancer transcriptome
2023, Progress in Biophysics and Molecular BiologyFunctional high-throughput screen identifies microRNAs that promote butyrate-induced death in colorectal cancer cells
2022, Molecular Therapy Nucleic AcidsT Cell Receptor Protein Sequences and Sparse Coding: A Novel Approach to Cancer Classification
2024, Communications in Computer and Information Science